Treatment for Pollen Allergies
For initial treatment of seasonal pollen allergies, prescribe an intranasal corticosteroid as monotherapy—this is the most effective first-line option with strong evidence supporting superior symptom control. 1
First-Line Treatment Algorithm
Standard Initial Therapy (Ages 12+)
- Intranasal corticosteroids alone (e.g., fluticasone propionate, mometasone) are the gold standard for initial treatment 1
- Do NOT routinely add oral antihistamines to intranasal corticosteroids for initial therapy—combination provides no additional benefit 1
- Intranasal corticosteroids are significantly more effective than oral leukotriene receptor antagonists (montelukast) for symptom reduction 1
When Patients Cannot Tolerate Intranasal Steroids
- Oral leukotriene receptor antagonists (montelukast) can be prescribed as an alternative, though they are less effective 1
- This may be appropriate for patients who refuse nasal sprays or have concurrent mild persistent asthma 1
Step-Up Therapy for Moderate-to-Severe Disease
Combination Therapy Option
- For patients with moderate-to-severe symptoms inadequately controlled on intranasal corticosteroids alone, consider adding an intranasal antihistamine (azelastine) 1
- The combination of fluticasone propionate plus azelastine provides clinically meaningful additional symptom reduction compared to either agent alone 1
- Symptom score reductions: combination therapy (-5.31 to -5.7) > fluticasone alone (-3.84 to -5.1) > azelastine alone (-3.25 to -4.54) > placebo (-2.2 to -3.03) 1
Important Caveats for Combination Therapy
- This is a weak recommendation due to increased cost, potential for adverse effects (dysgeusia 2-14%, minimal somnolence 0.4-1.1%), and limited quality-of-life improvement beyond symptom scores 1
- Patients using combination therapy require comedication less frequently (30-35% of days) compared to those on intranasal corticosteroids alone (45-60% of days) 1
What NOT to Prescribe Initially
- Avoid oral antihistamines added to intranasal corticosteroids for initial treatment—no demonstrated benefit 1
- Among oral antihistamines, cetirizine shows superior efficacy to loratadine (36.7% vs 15.4% symptom reduction), with faster onset of action (1 hour vs 3 hours) 2
Additional Treatment Considerations
Allergen Immunotherapy
- Subcutaneous immunotherapy (SCIT) is more effective than sublingual immunotherapy (SLIT) for grass pollen allergies, with greater symptom score reduction (SMD -0.92 vs -0.25 to -0.40) 3
- SLIT tablets show only small benefit (SMD -0.28 for symptoms, -0.24 for medication use) and should not replace pharmacotherapy as first-line treatment 4
- Immunotherapy is the only disease-modifying treatment option for long-term management 1
Real-World Treatment Patterns
- Patients typically self-medicate on-demand rather than following prescribed continuous regimens 1
- Adherence to guideline-recommended continuous therapy is poor in clinical practice 1
- Untreated days paradoxically show better control, suggesting patients appropriately reduce medication when symptoms are mild 1